Abstract:Objectives: To systematically investigate the expression, prognostic value, genetic alterations, immune infiltration, and molecular function of Nck-associated protein 1 (NCKAP1) in a pan-cancer analysis, with a specific focus on its association with kidney renal cell carcinoma (KIRC). Methods: We analyzed the role of NCKAP1 across various tumor types using data from The Cancer Genome Atlas (TCGA). The Gene Expression Profiling Interactive Analysis version 2 (GEPIA2) database was used to assess the correlation between NCKAP1 expression levels and overall survival (OS) and disease-free survival (DFS) across different cancers, as well as its association with cancer stage. Genetic alterations of NCKAP1 were explored using CBioPortal, and their prognostic implications were assessed. NCKAP1 was further analyzed through Gene Ontology and protein interaction network analyses. Immunohistochemistry (IHC) staining from the Human Protein Atlas (HPA) database evaluated NCKAP1 levels in KIRC tissues. Functional assays, including Cell Counting Kit-8 (CCK-8), colony formation, transwell, and wound healing assays, were conducted to determine the effects of NCKAP1 overexpression on cell growth rate and their ability to invade, proliferate, migrate in a KIRC (786-O) cell line. The relationship between NCKAP1 expression and immune infiltration in KIRC was systematically examined using the Tumor Immune Estimation Resource. Results: NCKAP1 expression was significantly altered in most tumor types compared to corresponding non-tumor tissues. Survival analysis indicated that low NCKAP1 expression was associated with poor OS, DFS, and advanced cancer stage (P < 0.05) specifically in KIRC. Genetic alterations in NCKAP1 were linked to clinical outcome in cancer patients, and a positive correlation was observed between NCKAP1 expression and cancer-associated fibroblast infiltration (P < 0.05). Gene Ontology analysis revealed that NCKAP1 regulates the actin cytoskeleton and interacts with proteins such as CYFIP1, ABI2, WASF2, and BRK1. IHC staining showed significantly lower NCKAP1 levels in KIRC tissues compared to normal tissues. Overexpression of NCKAP1 in KIRC cell lines reduced cell proliferation, invasion, and migration (P < 0.05). NCKAP1 was also positively correlated with macrophage, neutrophil, and CD4+ T cell infiltration (P < 0.001). Conclusion: NCKAP1 may serve as a prognostic and immunological marker and may be a therapeutic target for KIRC.

NKAP Functions As an Oncogene and Its Expression is Induced by CoCl2 Treatment in Breast Cancer Via AKT/mTOR Signaling Pathway.

NKAIN1, as an oncogene, promotes the proliferation and metastasis of breast cancer, affecting its prognosis

Nuclear Factor-κB Activating Protein Plays an Oncogenic Role in Neuroblastoma Tumorigenesis and Recurrence Through the Phosphatidylinositol 3-Kinase/Protein Kinase B Signaling Pathway

Interplay Of Mkp-1 And Nrf2 Drives Tumor Growth And Drug Resistance In Non-Small Cell Lung Cancer

High Kpnβ1 Expression Promotes Non-Small Cell Lung Cancer Proliferation and Chemoresistance Via the PI3-kinase/AKT Pathway.

NCKAP1 as a prognostic and immunological biomarker: pan-cancer analysis and validation in renal clear cell carcinoma

Identification of KCNK1 As a Potential Prognostic Biomarker and Therapeutic Target of Breast Cancer

NCKAP1 Improves Patient Outcome and Inhibits Cell Growth by Enhancing Rb1/p53 Activation in Hepatocellular Carcinoma.

CPNE1 Predicts Poor Prognosis and Promotes Tumorigenesis and Radioresistance Via the AKT Singling Pathway in Triple-Negative Breast Cancer

Impaired Dnkap Function Drives Genome Instability and Tumorigenic Growth in Drosophila Epithelia.

CKAP2 promotes cervical cancer progression by modulating the tumor microenvironment via NF-κB signaling.

KCTD12 Promotes G1/S Transition of Breast Cancer Cell Through Activating the AKT/FOXO1 Signaling

KCNK1 promotes proliferation and metastasis of breast cancer cells by activating lactate dehydrogenase A (LDHA) and up-regulating H3K18 lactylation

Original CKAP2 promotes cervical cancer progression by modulating the tumor microenvironment via NF-KB signaling

NKILA, a Prognostic Indicator, Inhibits Tumor Metastasis by Suppressing NF-κB/Slug Mediated Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma.

Promoting Proliferation and Tumorigenesis of Breast Cancer: KCND2's Significance As a Prognostic Factor

Overexpression of CKAP4 is Associated with Poor Prognosis in Clear Cell Renal Cell Carcinoma and Functions via Cyclin B Signaling.

NK4 Regulates Laryngeal Squamous Cell Carcinoma Cell Properties and Inhibits Tumorigenicity by Modulating the DKK1/Wnt/-Catenin Axis

KCNK3 inhibits proliferation and glucose metabolism of lung adenocarcinoma via activation of AMPK-TXNIP pathway

The Molecular Mechanism of Kinesin Family Member 2A (KIF2A) Underlying Non-Small Cell Lung Cancer: the Effect of Its Knockdown on Malignant Behaviors, Stemness, Chemosensitivity, and Potential Regulated Signaling Pathways.

Shrna‑mediated Knockdown of KNTC1 Inhibits Non-Small-cell Lung Cancer Through Regulating PSMB8